Literature DB >> 33668288

The Incidence of Healthcare-Associated Infections, Their Clinical Forms, and Microbiological Agents in Intensive Care Units in Southern Poland in a Multicentre Study from 2016 to 2019.

Elżbieta Rafa1, Marta Z Wałaszek2, Michał J Wałaszek3, Adam Domański4, Anna Różańska5.   

Abstract

INTRODUCTION: Healthcare-associated infections (HAIs) are a serious problem of modern medicine. Patients hospitalized in intensive care units (ICUs) develop HAI significantly more often than patients in other hospital units.
MATERIALS AND METHODS: Analysis involved HAIs from three ICUs in southern Poland. The study was conducted in 2016-2019 on the basis of methodology recommended by the Healthcare-Associated Infections Surveillance Network (HAI-Net) and European Centre for Disease Prevention and Control (ECDC). The objective was to analyse HAIs, their clinical forms, and microbiological agents.
RESULTS: The study included 3028 patients hospitalized for 26,558 person-days (pds) in ICU. A total of 540 HAIs were detected; incidence per 100 hospitalizations was 17.8%, incidence density per 1000 pds was 20.3. The mortality of patients with HAI was 16%, and in Clostridioidesdifficile infection (CDI), the mortality was 28%. The most common clinical form of HAI was bloodstream infection (BSI): 209 cases (incidence rate 6.9%), followed by pneumonia (PN): 131 (incidence rate 4.3%), and urinary tract infection (UTI): 110 cases (incidence rate 3.6%). The most frequently isolated bacteria were Klebsiella pneumoniae 16.4%, Acinetobacter baumannii 14.4%, Staphylococcus aureus 11.8%, and Escherichia coli 11.4%.
CONCLUSIONS: A two-fold higher incidence rate of BSI was detected compared to the average incidence in European countries. BSI of unknown source (BSI-UNK) was predominant. K. pneumoniae and A. baumannii bacteria were the most often isolated microorganisms causing HAI. Infection control based on incidence rate for each type of infection is necessary in ICU to assess the epidemiological situation.

Entities:  

Keywords:  Acinetobacter baumannii; Klebsiella pneumoniae; bloodstream infection; healthcare-associated infections (HAI); intensive care unit (ICU); pneumonia; urinary tract infection

Mesh:

Year:  2021        PMID: 33668288      PMCID: PMC7956275          DOI: 10.3390/ijerph18052238

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  25 in total

Review 1.  Infection control and the prevention of nosocomial infections in the intensive care unit.

Authors:  Gonzalo M L Bearman; Cindy Munro; Curtis N Sessler; Richard P Wenzel
Journal:  Semin Respir Crit Care Med       Date:  2006-06       Impact factor: 3.119

2.  Epidemiology of healthcare-associated infections in Polish intensive care. A multicenter study based on active surveillance.

Authors:  Michal Walaszek; Anna Rozanska; Malgorzata Bulanda; Jadwiga Wojkowska-Mach; Polish Society Of Hospital Infections Team
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2018-03-01       Impact factor: 1.245

3.  [Monitoring of nosocomial infections in intensive care units].

Authors:  Sylwia Wieder-Huszla
Journal:  Ann Acad Med Stetin       Date:  2010

4.  [Hospital acquired pneumonia at the intensive care units. The active nosocomial infections surveillance programme of Polish Society of Hospital Infections].

Authors:  Jadwiga Wójkowska-Mach; Małgorzata Bulanda; Anna Rózańska; Piotr B Heczko
Journal:  Przegl Epidemiol       Date:  2006

5.  Urinary tract infections in intensive care unit patients - a single-centre, 3-year observational study according to the INICC project.

Authors:  Wiesława Duszyńska; Victor D Rosenthal; Aleksander Szczęsny; Ewa Woźnica; Klaudia Ulfik; Elżbieta Ostrowska; Agnieszka Litwin; Andrzej Kübler
Journal:  Anaesthesiol Intensive Ther       Date:  2016

6.  Multimodal surveillance of healthcare associated infections in an intensive care unit of a large teaching hospital.

Authors:  G Migliara; C Di Paolo; D Barbato; V Baccolini; C Salerno; A Nardi; F Alessandri; A Giordano; D Tufi; L Marinelli; A Cottarelli; M De Giusti; C Marzuillo; C De Vito; G Antonelli; M Venditti; G Tellan; M V Ranieri; P Villari
Journal:  Ann Ig       Date:  2019 Sep-Oct

7.  Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study.

Authors:  Peter J Pronovost; Christine A Goeschel; Elizabeth Colantuoni; Sam Watson; Lisa H Lubomski; Sean M Berenholtz; David A Thompson; David J Sinopoli; Sara Cosgrove; J Bryan Sexton; Jill A Marsteller; Robert C Hyzy; Robert Welsh; Patricia Posa; Kathy Schumacher; Dale Needham
Journal:  BMJ       Date:  2010-02-04

8.  The acquisition and outcome of ICU-acquired Clostridium difficile infection in a single centre in the UK.

Authors:  Chin Wee Ang; Graham Heyes; Paul Morrison; Bryan Carr
Journal:  J Infect       Date:  2008-11-17       Impact factor: 6.072

9.  Information on nosocomial infections in the mainstream media: an opinion document.

Authors:  E Bouza; S Alonso; A Asensio; G De Juan; C García Lucio; C Larrosa; J López-Iglesias; P Muñoz; R Sierra; J Perianes; J L De la Serna; E Palomo; D Gracia
Journal:  Rev Esp Quimioter       Date:  2019-03-18       Impact factor: 1.553

View more
  3 in total

1.  Healthcare-associated infections in COVID-19 ICU patients - two-centre study.

Authors:  Bartosz Kozłowski; Joanna Kubiak-Pulkowska; Julianna Pałka; Dominika Bożiłow; Magdalena Zając; Aleksander Deptuła
Journal:  Cent Eur J Public Health       Date:  2022-09       Impact factor: 1.154

2.  Healthcare-Acquired Infection Surveillance in Neurosurgery Patients, Incidence and Microbiology, Five Years of Experience in Two Polish Units.

Authors:  Elżbieta Rafa; Małgorzata Kołpa; Marta Zofia Wałaszek; Adam Domański; Michał Jan Wałaszek; Anna Różańska; Jadwiga Wójkowska-Mach
Journal:  Int J Environ Res Public Health       Date:  2022-06-20       Impact factor: 4.614

Review 3.  The immune responses to different Uropathogens call individual interventions for bladder infection.

Authors:  Linlong Li; Yangyang Li; Jiali Yang; Xiang Xie; Huan Chen
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.